Outcomes of patients with recurrent and refractory lymphoma undergoing allogeneic hematopoietic cell transplantation with BEAM conditioning and sirolimus and tacrolimus based GVHD prophylaxis.

Salhotra, A., Mei, M., Stiller, T., Mokhtari, S., Herrera, A.F., Chen, R., Popplewell, L., Zain, J., Ali, H., Sandhu, K., et al. (2018). Outcomes of patients with recurrent and refractory lymphoma undergoing allogeneic hematopoietic cell transplantation with BEAM conditioning and sirolimus and tacrolimus based GVHD prophylaxis.Biol Blood Marrow Transplant.